DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Desipramine Hydrochloride is a drug marketed by Actavis Totowa, Amneal Pharms Co, Ani Pharms Inc, Heritage Pharms Inc, Novast Labs, Sandoz, and Usl Pharma. and is included in twenty NDAs.
The generic ingredient in DESIPRAMINE HYDROCHLORIDE is desipramine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.
A generic version of DESIPRAMINE HYDROCHLORIDE was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5th, 1987.
Recent Clinical Trials for DESIPRAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Duke University||Phase 4|
|Stanford University||Phase 4|
|Astellas Pharma Inc||Phase 4|
Pharmacology for DESIPRAMINE HYDROCHLORIDE
|Drug Class||Tricyclic Antidepressant |